Preparing for a Potential Breakout Opportunity

Hey Gang, I hope you all had a wonderful Thanksgiving and holiday. As you know, I was mainly out last week due to the holiday; however, I am back this morning! As we begin a new week, I think many biotech bulls will quickly want to forget last week! I say this, of course, because the XBI was down 4.45% on the week after suffering two significant red days, on Monday and Friday. The ETF, which tracks small-cap biotech stocks, is now trading below critical support at $120. Bulls might not want to see the ETF continue to base below $120, thereby turning that support into newfound resistance. If the ETF continues to base below and build on this downtrend, it might negatively affect small-cap biotech stocks. Hopefully, the XBI will find support in the $115 - $120 area and bounce towards the 50d MA, $125. With the overall weakness and pressure experienced in the biotech sector and general market, I am looking to remain patient, disciplined, and stock selective this week. The breakdown in the sector last week adds an extra layer of difficulty. Therefore, I need to be highly prepared and focused on the correct stocks and opportunities to experience momentum to the upside in a seemingly weak market. One such stock, which I recently added and shared with my members is MNOV. [Continue reading….]( Jeff Williams RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Unsubscribe from all RagingBull emails]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.